NFKB1 and chronic kidney disease: Nuclear factor-kappa B (NF-κB) is also known to be important in the expression of pro-inflammatory genes, and treatment with the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) shows attenuated renal injury and inflammation in animal models of CKD [12].